Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Acadia Healthcare Company, Inc. (ACHC) has a Wall Street consensus price target of $19.82, based on estimates from 25 covering analysts. With the stock currently trading at $23.44, this represents a potential downside of -15.4%. The company has a market capitalization of $2.12B.
Analyst price targets range from a low of $14.00 to a high of $25.00, representing a 55% spread in expectations. The median target of $20.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 16 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ACHC trades at a trailing P/E of -1.9x and forward P/E of 15.7x. Analysts expect EPS to grow +112.3% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ACHC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonACHC's consensus price target is $19.82, -15.4% below the current price of $23.44. The 25 analysts tracking ACHC see downside risk at present valuations.
ACHC has a consensus rating of "Buy" based on 25 Wall Street analysts. The rating breakdown is predominantly bullish, with 16 Buy/Strong Buy ratings. The consensus 12-month price target of $19.82 implies -15.4% downside from current levels.
With a forward P/E of 15.6831x, ACHC trades at a relatively low valuation. The consensus target of $19.82 implies -15.4% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $25 for ACHC, while the most conservative target is $14. The consensus of $19.82 represents the median expectation. These targets typically reflect 12-month expectations.
ACHC is heavily covered by Wall Street, with 25 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ACHC stock forecast based on 25 Wall Street analysts shows a consensus price target of $19.82, with estimates ranging from $14 (bear case) to $25 (bull case). The median consensus rating is "Buy".
ACHC trades at a forward P/E ratio of 15.7x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ACHC, with 1 Sell ratings and a price target of $19.82 (-15.4% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ACHC analyst price targets range from $14 to $25, a 55% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $19.82 consensus represents the middle ground.